Skip to NavigationSkip to content

News

0
The FDA is looking into if the diabetes drug metformin has unsafe levels of a cancer-causing chemical.
0
Sage Therapeutics has announced that its candidate SAGE-217 flopped in Phase 3 trials investigating its efficacy in symptom reduction for major...
0
Over 140,000 people died from measles last year, with most of them being children under five, according to World Health Organization (WHO) and the US...
0
Widespread bribery in India’s pharma industry, Purdue Pharma President ignored addiction concerns with OxyContin, and Lynparza scores NICE...

Features

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis and experience with the UK...